James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 7,894 shares at $74.44 ($609K) on 2024-03-12, disclosed to the SEC on 2024-03-12.
Seasonal sale ($609k) by General Counsel and Secretary — this insider has traded CRSP in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.26 | 2,801 | $219K | 36.0% |
| 2 | $78.26 | 2,801 | $219K | 36.0% |
| 3 | $74.44 | 1,146 | $85K | 14.0% |
| 4 | $74.44 | 1,146 | $85K | 14.0% |
| Total | $77.15 avg | 7,894 | $609K | 100% |
| Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |